Pesquisar
Mainz Biomed NV
MYNZAdicionar à lista de desejos
0.844USD
0.0000.00%
Fechamento 07/01, 16:00（ET）Cotações atrasadas em 15 min
35.06MValor de mercado
PerdaP/L TTM
Mais detalhes de Mainz Biomed NV Empresa
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Informações de Mainz Biomed NV
Código da empresaMYNZ
Nome da EmpresaMainz Biomed NV
Data de listagemNov 04, 2021
CEOBaechler (Guido)
Número de funcionários19
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 04
EndereçoSirius Gutenberg Park
CidadeMAINZ
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal55129
Telefone496131265140
Sitehttps://www.mainzbiomed.com/
Código da empresaMYNZ
Data de listagemNov 04, 2021
CEOBaechler (Guido)
Executivos da empresa Mainz Biomed NV
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Mainz Biomed NV?
Os cinco principais acionistas de Mainz Biomed NV são: Dr. Heiner Dreismann, Ph.D.
Quantas instituições possuem ações da Mainz Biomed NV (MYNZ)?
Em 2026Q1, 33 instituições possuíam ações da Mainz Biomed NV, com valor de mercado aproximado de 1.23M, representando 9.84% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 663009.00.